Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Cooperative Interaction Between C-myc And Bcl-2 Proto-oncogenes

A. Fanidi, E. A. Harrington, G. Evan
Published 1992 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
THE bcl-2 proto-oncogene is activated by translocation in a variety of B-lymphoid tumours and synergizes with the c-myc oncogene in tumour progression1. The mechanism of synergy is unclear but bcl-2 expression inhibits apoptosis2–6, a property presumably pertinent to its proto-oncogenic mode of action4. We have shown that the c-myc gene is a potent inducer of apoptosis, in addition to its established role in mitogenesis7. Here we show that expression of the bcl-2 protein, Bcl-2, specifically abrogates c-mvoinduced apoptosis without affecting the c-myc mitogenic function. This provides a novel mechanism for oncogene cooperation, of potential importance both in carcinogenesis and in the evolution of drug resistance in tumours.
This paper references
10.1128/MCB.10.8.4370
Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts.
John Calvin Reed (1990)
10.1042/BST0180343
Induction of apoptosis (programmed cell death) in tumour cell lines by widely diverging stimuli.
S. Lennon (1990)
10.1038/349254A0
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)
Timothy J. McDonnell (1991)
10.1038/348334A0
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
D. Hockenbery (1990)
10.1002/PATH.1711530404
Apoptosis: Cell death in tissue regulation
A. Wyllie (1987)
10.3109/02841869109091819
Genetic mechanisms of drug resistance. A review.
P. Borst (1991)
10.1146/ANNUREV.BI.58.070189.002031
DNA topoisomerase poisons as antitumor drugs.
L. Liu (1989)
10.1038/335440A0
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
D. Vaux (1988)
10.1016/0092-8674(91)90362-3
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
A. Strasser (1991)
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
D. Askew (1991)
10.1002/j.1460-2075.1991.tb07929.x
The MYC protein activates transcription of the alpha‐prothymosin gene.
M. Eilers (1991)
10.1038/340066A0
Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
M. Eilers (1989)
10.1016/0092-8674(91)90361-2
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
C. Sentman (1991)
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
F. Pezzella (1990)
10.1038/348331A0
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
A. Strasser (1990)
10.1016/0092-8674(85)90030-3
Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins
G. Evan (1985)
10.1093/NAR/18.12.3587
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
J. Morgenstern (1990)
10.1016/S0065-230X(08)60476-5
Control of c-myc regulation in normal and neoplastic cells.
C. Spencer (1991)
10.1016/0092-8674(90)90293-N
Structure and polymorphism of human telomere-associated DNA
W. Brown (1990)
10.1038/304596A0
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
H. Land (1983)
10.1139/O90-160
The biochemistry of cell death by apoptosis.
W. Bursch (1990)
10.1016/0092-8674(92)90123-T
Induction of apoptosis in fibroblasts by c-myc protein
G. Evan (1992)



This paper is referenced by
10.1128/JVI.76.5.2087-2099.2002
Selection for c-myc Integration Sites in Polyclonal T-Cell Lymphomas
D. R. Broussard (2002)
10.1111/j.1349-7006.2003.tb01358.x
Evodiamine, a constituent of Evodiae Fructus, induces anti‐proliferating effects in tumor cells
Xiao Fei (2003)
10.1038/nature08822
The landscape of somatic copy-number alteration across human cancers
R. Beroukhim (2010)
10.1002/1097-0290(20001120)70:4<421::AID-BIT7>3.0.CO;2-S
Effect of insulin stimulation on the proliferation and death of Chinese hamster ovary cells.
A. Sanfeliu (2000)
10.1016/S1535-6108(03)00088-6
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase.
J. Zhao (2003)
10.1002/jcb.10519
Increased gap junctional intercellular communication is directly related to the anti‐tumor effect of all‐trans‐retinoic acid plus tamoxifen in a human mammary cancer cell line
C. Sáez (2003)
Apoptosis in the Embryo and Tumorigenesis
John H. Fetting (1995)
10.1007/978-1-4684-8437-3_11
Apoptosis and Cancer
Fruma Yehiely (2000)
Elucidating the Mechanism by which KRI-1/CCM1 Regulates Apoptosis Cell Non-Autonomously in Caenorhabditis elegans
E. M. Chapman (2018)
Characterisation of the Fit-1 common integration locus.
Barr Ni (1999)
10.1007/978-1-4615-4811-9_35
BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
E. Haarman (1999)
10.1084/JEM.183.5.2219
Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death
S. Mazel (1996)
CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
A. Yi (1998)
10.1002/(SICI)1097-0215(19970529)71:5<709::AID-IJC2>3.0.CO;2-V
Cancer‐A matter of life and cell death
G. Evan (1997)
10.1006/BBRC.1997.6969
Lack of induction of tissue transglutaminase but activation of the preexisting enzyme in c-Myc-induced apoptosis of CHO cells.
Z. Balajthy (1997)
10.1007/978-1-4899-0274-0_25
Autoimmunity due to defective Nur77, Fas, and TNF-RI apoptosis.
J. Mountz (1996)
10.1046/J.1365-2141.2000.02431.X
Antisense oligonucleotides complementary to immunoglobulin sequences of BCL-2/immunoglobulin fusion transcript induce apoptosis of t(14;18) lymphoma cells.
M. Smith (2000)
10.1016/1043-6618(94)80034-0
Cell survival and death programmes.
V. Chiarugi (1994)
10.1016/0378-1119(95)00159-4
Cloning, characterization and expression of two Xenopus bcl-2-like cell-survival genes.
J. Cruz-Reyes (1995)
10.1007/978-3-642-79275-5_37
A link between the antioxidant defense system and calcium: a proposal for the biochemical function of Bcl-2.
G. Bornkamm (1995)
10.2174/1568009033481949
The MYC oncogene as a cancer drug target.
H. Hermeking (2003)
different sensitivity to glucocorticoid-induced apoptosis BCL-2 expression and mitochondrial activity in leukemic cells
LA Smets (2002)
10.1186/s13045-018-0608-2
BCL-2 as therapeutic target for hematological malignancies
G. Perini (2018)
10.1128/9781555818302.CH10
Progress in the Molecular Medicine of Cancer
S. Broder (1995)
Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
K. Mitchell (2000)
10.1016/S0145-2126(01)00100-X
Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Waleed F. Khalaf (2002)
10.1002/jcp.20194
Rapid induction of the intrinsic apoptotic pathway by L‐glutamine starvation
Julie C Paquette (2005)
10.3109/10428199609051608
Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells.
L. Smets (1996)
10.1002/IJC.2910590102
bcl‐2 expression in normal breast tissue during the menstrual cycle
J. C. Sabourin (1994)
Bcl-2 Protein Expression inLungCancer and CloseCorrelation withNeuroendocrine Differentiation
Shi-Xu Jiang (1996)
10.1007/978-1-4615-5873-6_7
The functions of Myc in cell cycle progression and apoptosis.
Philipp Hendrik Steiner (1996)
10.1093/JNCI/88.5.279
Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
Y. Kang (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar